Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial

W.W. Fleischhacker; C.O. Siu; R. Boden; E. Pappadopulos; O.N. Krarayal; x EUFEST Study Group; X et al; R.S. Kahn

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial

Translated title of the contribution: Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial

W.W. Fleischhacker, C.O. Siu, R. Boden, E. Pappadopulos, O.N. Krarayal, x EUFEST Study Group, X et al, R.S. Kahn

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
Original language	Undefined/Unknown
Pages (from-to)	987-995
Number of pages	9
Journal	International Journal of Neuropsychopharmacology
Volume	16
Issue number	5
Publication status	Published - 2013

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23253821

Cite this

Fleischhacker, W. W., Siu, C. O., Boden, R., Pappadopulos, E., Krarayal, O. N., EUFEST Study Group, X., et al, X., & Kahn, R. S. (2013). Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. International Journal of Neuropsychopharmacology, 16(5), 987-995. http://www.ncbi.nlm.nih.gov/pubmed/23253821

@article{fe5fae617b4a48b6863fbb4af62f959d,

title = "Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "W.W. Fleischhacker and C.O. Siu and R. Boden and E. Pappadopulos and O.N. Krarayal and {EUFEST Study Group}, x and {et al}, X and R.S. Kahn",

year = "2013",

language = "Undefined/Unknown",

volume = "16",

pages = "987--995",

journal = "International Journal of Neuropsychopharmacology",

issn = "1461-1457",

publisher = "Oxford University Press",

number = "5",

}

Fleischhacker, WW, Siu, CO, Boden, R, Pappadopulos, E, Krarayal, ON, EUFEST Study Group, X, et al, X & Kahn, RS 2013, 'Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial', International Journal of Neuropsychopharmacology, vol. 16, no. 5, pp. 987-995. <http://www.ncbi.nlm.nih.gov/pubmed/23253821>

TY - JOUR

T1 - Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial

AU - Fleischhacker, W.W.

AU - Siu, C.O.

AU - Boden, R.

AU - Pappadopulos, E.

AU - Krarayal, O.N.

AU - EUFEST Study Group, x

AU - et al, X

AU - Kahn, R.S.

PY - 2013

Y1 - 2013

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1461-1457

VL - 16

SP - 987

EP - 995

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

IS - 5

ER -